行业推广癌症药物,加速批准已失败的确认试验
Maryam Mooghali1,2, Reshma Ramachandran1,2, Ayman Mohammad3
1Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Journal of the National Cancer Institute
|August 26, 2025
概括
即使在证实性研究失败后,一些瘤药物也继续向医生支付. 这种促销持续到市场撤销,引发了对加速批准药物的担忧.
科学领域:
- 癌症学
- 制药行业
- 医疗经济学
背景情况:
- 加速批准途径允许早期药物获取,但需要确认性研究.
- 医疗行业向医生支付的费用可能会影响处方模式.
- 人们担心继续推广未通过市场研究的药物.
研究的目的:
- 分析行业对获得加速批准的瘤药物的支付,
- 评估负面确认研究结果之前和之后的支付趋势.
主要方法:
- 在2009-2021年间获得加速批准的瘤药物的回顾性分析.
- 使用开放支付数据来追踪行业对医生的支付.
- 在公布负面确认研究结果之前和之后的支付数据.
主要成果:
- 在73种加速批准的瘤药物中,有6种具有负面的确认性研究和可用的支付数据.
- 这些药物在负面结果后的中位数为0.3年后被取消.
- 对于四种药物,产业支付下降,但负面后的结果仍在继续:温克里斯硫酸盐,帕诺比诺斯塔特,贝兰塔马夫多丁和乌布拉利西布.
结论:
- 在确认性研究失败后,行业对某些瘤药物进行了推广.
- 医生付款一直持续到某些加速批准药物的市场撤销.
- 这凸显了对加速批准途径中的药物进行仔细监测的需要.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.5K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Drug Administration and Therapy Phases: Overview
738
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
738
Drug Regulation
1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
